[1]
|
Mao, F.-Y., Kong, H., Zhao, Y.-L., et al. (2017) Increased Tumor-Infiltrating CD45RA−CCR7− Regulatory T-Cell Subset with Immunosuppressive Properties Foster Gastric Cancer Progress. Cell Death & Disease, 8, e3002.
https://doi.org/10.1038/cddis.2017.388
|
[2]
|
Bourreille, J., Metayer, P., Sauger, F., Matray, F. and Fondimare, A. (1970) Existence of α-Fetoprotein during Gastric-Origin Secondary Cancer of the Liver. La Presse Médicale, 78, 1277-1278. (In French)
|
[3]
|
Hirajima, S., Komatsu, S., Ichikawa, D., et al. (2013) Liver Metastasis Is the Only Inde-pendent Prognostic Factor in AFP-Producing Gastric Cancer. World Journal of Gastroenterology, 19, 6055-6061.
https://doi.org/10.3748/wjg.v19.i36.6055
|
[4]
|
Wang, D., Li, C., Xu, Y., Xing, Y., Qu, L., Guo, Y., et al. (2015) Clinicopathological Characteristics and Prognosis of Alpha-Fetoprotein Positive Gastric Cancer in Chinese Patients. International Journal of Clinical and Experimental Pathology, 8, 6345-6355.
|
[5]
|
Feng, Y., Li, Y., Dai, W., Mo, S., Li, Q., et al. (2018) Clinicopathologic Features and Prognostic Factors in Alpha- Fetoprotein-Producing Colorectal Cancer: Analysis of 78 Cases. Cellular Physiology and Biochemistry, 51, 2052-2064.
https://doi.org/10.1159/000495824
|
[6]
|
Kinjo, T., Taniguchi, H., Kushima, R., Sekine, S., Oda, I., et al. (2012) Histologic and Immunohistochemical Analyses of α-Fetoprotein—Producing Cancer of the Stomach. The American Journal of Surgical Pathology, 36, 56-65.
https://doi.org/10.1097/PAS.0b013e31823aafec
|
[7]
|
Zheng, Y., Zhu, M. and Li, M. (2020) Effects of Al-pha-Fetoprotein on the Occurrence and Progression of Hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 146, 2439-2446.
https://doi.org/10.1007/s00432-020-03331-6
|
[8]
|
Sentani, K., Uraoka, N., Oue, N., et al. (2014) Al-pha-Fetoprotein-Producing Clear Cell Carcinoma of the Gallbladder with Neuroendocrine Differentiation. Medical Molecular Morphology, 47, 54-56.
https://doi.org/10.1007/s00795-013-0049-5
|
[9]
|
Wang, Q., Liu, B., Qiao, W., et al. (2021) The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma after Locoregional Therapy: A 5-Year Prospective Cohort Study. Frontiers in Oncology, 11, Article 756363. https://doi.org/10.3389/fonc.2021.756363
|
[10]
|
Yamamura, N. and Kishimoto, T. (2012) Epigenetic Regulation of GATA4 Expression by Histone Modification in AFP-Producing Gastric Adenocarcinoma. Experimental & Molecular Pathology, 93, 35-39.
https://doi.org/10.1016/j.yexmp.2012.03.012
|
[11]
|
Kamei, S., Kono, K., Amemiya, H., et al. (2003) Evaluation of VEGF and VEGF-C Expression in Gastric Cancer Cells Producing α-Fetoprotein. Journal of Gastroenterology, 38, 540-547. https://doi.org/10.1007/s00535-002-1099-y
|
[12]
|
刘佳, 白玉贤, 魏孝礼. 甲胎蛋白阳性胃癌相关基因及治疗的研究进展[J]. 中国肿瘤, 2018, 27(6): 442-447.
|
[13]
|
方瑜, 王琳, 李桂梅, 张瑜, 杨宁蓉, 秦叔逵. c-Met、VEGF、EGFR和HER-2在AFP阳性胃癌中的表达研究[J]. 中国癌症杂志, 2016, 26(8): 662-669.
|
[14]
|
Zhou, F., Shang, W., Yu, X. and Tian, J. (2018) Glypican-3: A Promising Biomarker for Hepatocellular Carcinoma Diagnosis and Treatment. Medicinal Research Reviews, 38, 741-767. https://doi.org/10.1002/med.21455
|
[15]
|
Matsumoto, K., Ueyama, H., Matsumoto, K., et al. (2016) Clinicopathological Features of Alpha-Fetoprotein Producing Early Gastric Cancer with Enteroblastic Differentiation. World Journal of Gastroenterology, 22, 8203-8210.
https://doi.org/10.3748/wjg.v22.i36.8203
|
[16]
|
Iwaya, M., Riddell, R., Asano, K., Kobayashi, K., Uehara, T. and Ota, H. (2020) Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Dif-ferentiation. Case Reports in Gastroenterology, 14, 426-435. https://doi.org/10.1159/000508413
|
[17]
|
杨建, 周业江. AFP阳性胃癌多药耐药蛋白水平的研究[J]. 胃肠病学和肝病学杂志, 2017, 26(12): 1365-1369.
|
[18]
|
Ren, F., Weng, W., Zhang, Q., Tan, C., et al. (2019) Clinicopathological Features and Prognosis of AFP-Producing Colorectal Cancer: A Single-Center Analysis of 20 Cases. Cancer Management and Research, 11, 4557-4567.
https://doi.org/10.2147/CMAR.S196919
|
[19]
|
Forghanifard, M.-M., Moghbeli, M., Raeisossadati, R., et al. (2013) Role of SALL4 in the Progression and Metastasis of Colorectal Cancer. Journal of Biomedical Science, 20, Article No. 6. https://doi.org/10.1186/1423-0127-20-6
|
[20]
|
谢继光, 闫晓晓, 董永红. 甲胎蛋白阳性胃癌研究现状与进展[J]. 中国临床研究, 2019, 32(12): 1727-1730.
|
[21]
|
He, L., Ye, F., Qu, L., et al. (2016) Protein Profiling of Al-pha-Fetoprotein Producing Gastric Adenocarcinoma. Oncotarget, 7, 28448-28459. https://doi.org/10.18632/oncotarget.8571
|
[22]
|
Søreide, J.A., Greve, O.J., Gudlaugsson, E. and Størset, S. (2016) Hepatoid Adenocarcinoma of the Stomach—Proper Identification and Treatment Remain a Challenge. Scandinavian Journal of Gastroenterology, 51, 646-653.
https://doi.org/10.3109/00365521.2015.1124286
|
[23]
|
Anzai, H., Kazama, S., Kiyomatsu, T., et al. (2015) Al-pha-Fetoprotein-Producing Early Rectal Carcinoma: A Rare Case Report and Review. World Journal of Surgical On-cology, 13, Article No. 180.
https://doi.org/10.1186/s12957-015-0590-x
|
[24]
|
沈洪章, 朱家沂, 于鸿, 杨斌. 产甲胎蛋白胰腺癌一例并文献复习[J]. 中华全科医师杂志, 201, 11(10): 796-797.
|
[25]
|
张永一, 葛军辉, 蔡洪培. 产甲胎蛋白胰腺癌二例及文献复习[J]. 中华胰腺病杂志, 2011, 11(11): 61-63.
|
[26]
|
Akturk, G., Sagol, O., Unek, T., et al. (2018) Al-pha-Fetoprotein-Secreting Gallbladder Carcinoma: A Case Report. Journal of Gastrointestinal Cancer, 49, 528-531. https://doi.org/10.1007/s12029-017-9950-9
|
[27]
|
Dixit, N., Trivedi, S. and Bansal, V.K. (2021) Clear-Cell Ade-nocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature. Gas-trointestinal Tumors, 8, 52-57.
https://doi.org/10.1159/000512955
|
[28]
|
Kong, X.-X., Li, X.-L., Tian, Y., et al. (2021) The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract—A Single-Center Ret-rospective Study. Frontiers in Oncology, 11, Article 635537. https://doi.org/10.3389/fonc.2021.635537
|
[29]
|
He, R., Yang, Q., Dong, X., Wang, Y., Zhang, W., et al. (2017) Clinicopathologic and Prognostic Characteristics of Al-pha-Fetoprotein-Producing Gastric Cancer. Oncotarget, 8, 23817-23830. https://doi.org/10.18632/oncotarget.15909
|
[30]
|
徐军, 王健, 陈君平, 等. 伴血清甲胎蛋白升高的胃癌32例临床病理特征[J]. 临床与实验病理学杂志, 2021, 37(5): 600-603.
|
[31]
|
黄玉英, 柯莹, 魏晓珠. PDGF、BNP、AFP-L3在乙型肝炎肝硬化患者预后评估中的价值[J]. 热带医学杂志, 2019, 19(4): 477-480, 封3.
|
[32]
|
Longo, R., Carassou, P., Leguay, C., et al. (2021) A 50-Year-Old Man with Fulminant Alpha-Fetoprotein-Producing Gastric Car-cinoma and Disseminated Intravascular Coagulation. American Journal of Case Reports, 22, e928369.
https://doi.org/10.12659/AJCR.928369
|
[33]
|
杨燕峰, 董雪伟. 阿帕替尼治疗中晚期胃癌的临床疗效及预后影响因素[J]. 实用癌症杂志, 2017, 32(8): 1318-1320.
|
[34]
|
Lin, Y., Zhai, E., Liao, B., Xu, L., et al. (2017) Autocrine VEGF Signaling Promotes Cell Proliferation through a PLC-Dependent Pathway and Modulates Apatinib Treatment Efficacy in Gastric Cancer. Oncotarget, 8, 11990-12002.
https://doi.org/10.18632/oncotarget.14467
|
[35]
|
Lu, J., Ding, Y., Chen, Y., et al. (2021) Whole-Exome Sequencing of Alpha-Fetoprotein Producing Gastric Carcinoma Reveals Genomic Profile and Therapeutic Targets. Nature Communications, 12, Article No. 3946.
https://doi.org/10.1038/s41467-021-24170-0
|
[36]
|
Nakamura, Y., Matsuda, K., Yokoyama, S., et al. (2018) Al-pha-Fetoprotein-Producing Rectal Cancer Successfully Responded to Preoperative Chemoradiotherapy: Case Report. Surgical Case Reports, 4, Article No. 111.
https://doi.org/10.1186/s40792-018-0520-6
|
[37]
|
Kim, C.Y., Lee, S.H., Jeon, H.M., et al. (2014) AFP-Producing Acinar Cell Carcinoma Treated by Pancreaticoduodenectomy in a Patient with a Previous Radical Subtotal Gastrectomy by Gastric Cancer. Korean Journal of Hepato-Biliary-Pancreatic Surgery, 18, 33-37. https://doi.org/10.14701/kjhbps.2014.18.1.33
|
[38]
|
丁平安, 杨沛刚, 田园, 等. 血清甲胎蛋白阳性胃癌患者的临床病理学特征及预后分析[J]. 中国癌症杂志, 2020, 30(11): 887-896.
|
[39]
|
Wang, R., Li, J., Xu, D., Li, R. and Gong, P. (2020) Dynamic Change in Serum Alpha-Fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-Fetoprotein-Producing Gastric Cancer. Medicine, 99, e23326.
https://doi.org/10.1097/MD.0000000000023326
|
[40]
|
Reim, D., Choi, Y.-S., Yoon, H.-M., et al. (2017) Al-pha-Fetoprotein Is a Significant Prognostic Factor for Gastric Cancer: Results from a Propensity Score Matching Analysis after Curative Resection. European Journal of Surgical Oncology, 43, 1542-1549. https://doi.org/10.1016/j.ejso.2017.04.005
|
[41]
|
Wang, Y.-K., Shen, L., Jiao, X. and Zhang, X.-T. (2018) Predictive and Prognostic Value of Serum AFP Level and Its Dynamic Changes in Advanced Gastric Cancer Patients with Elevated Serum AFP. World Journal of Gastroenterology, 24, 266-273. https://doi.org/10.3748/wjg.v24.i2.266
|
[42]
|
Natsume, T., Watanabe, Y., Maruyama, T., Tanaka, H., et al. (2005) Successful Resection of a Liver Metastasis from AFP-Producing Pancreatic Cancer Resulting in Long-Term Survival. Pancreas, 31, 416-419.
https://doi.org/10.1097/01.mpa.0000179727.15716.82
|
[43]
|
Zhu, X., Yong, H., Zhang, L., et al. (2015) Pure Al-pha-Fetoprotein-Producing Neuroendocrine Carcinoma of the Pancreas: A Case Report. BMC Gastroenterology, 15, Article No. 16. https://doi.org/10.1186/s12876-015-0246-x
|